Anika Therapeutics | ANIK - Ebit





Ebit Veränderung Datum
Abbott USD 2.13B 281M 2026-06
Agenus USD 15.05M 656K 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -101.31M 98.97M 2026-06
Integra LifeSciences USD 41.29M 29.82M 2026-06
Intrexon USD -26.3M 2.91M 2024-06
J&J USD 7.48B 860M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
MacroGenics USD -31.88M 19.79M 2026-03
Merit Medical Systems USD 60.4M 16.25M 2026-06
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Sanofi EUR 1.12B 811M 2026-06
Smith & Nephew USD 505M 65M 2026-06
Stryker USD 1.79B 687M 2026-06
Veracyte USD 23.96M 4.88M 2026-06
Xencor USD -36.6M 41.26M 2026-06
Zimmer Biomet Holdings USD 344.7M 50.4M 2026-06